Glycobiology: August 2017
Synthesis and Characterization of Heparosan-Granulocyte-Colony Stimulating Factor Conjugates: a natural sugar-based drug delivery system to treat neutropenia
Synthesis and Characterization of Heparosan-Granulocyte-Colony Stimulating Factor Conjugates: a natural sugar-based drug delivery system to treat neutropenia
Glycobiology: August 2017
Heparosan-Coated Liposomes for Drug Delivery
Heparosan-Coated Liposomes for Drug Delivery
Poster Presented by Novo Nordisk A/S: July 2016
Increasing the in vivo half-life of factor VIIa by attachment of the natural polysaccharide heparosan
Courtesy of Novo Nordisk A/S
Increasing the in vivo half-life of factor VIIa by attachment of the natural polysaccharide heparosan
Courtesy of Novo Nordisk A/S
Poster Presented by Novo Nordisk A/S: June 2015
Heparosan glycol-conjugates of rFVIII and rFIX show prolonged circulating half-life in haemophilia mouse models
Courtesy of Novo Nordisk A/S
Heparosan glycol-conjugates of rFVIII and rFIX show prolonged circulating half-life in haemophilia mouse models
Courtesy of Novo Nordisk A/S
Drug Development and Delivery: January 2013
Heparosan-Based Conjugates – Heptune: A Process of Conjugating a Naturally Occurring Sugar Molecule, Heparosan, to a Drug for Enhanced Drug Delivery
Heparosan-Based Conjugates – Heptune: A Process of Conjugating a Naturally Occurring Sugar Molecule, Heparosan, to a Drug for Enhanced Drug Delivery
Drug Development and Delivery: July/August 2012
Caisson Biotech: Innovation in Drug Delivery Using a Naturally Occurring Sugar Molecule
Caisson Biotech: Innovation in Drug Delivery Using a Naturally Occurring Sugar Molecule
The Oklahoman: June 22, 2012
Drug Delivery System Agreement Opens Doors for Caisson Biotech
Drug Delivery System Agreement Opens Doors for Caisson Biotech
Drug Delivery News: June 2012
Hustling on Half-lives
Hustling on Half-lives